Program implementation review and updates on the different programs of the pharmaceutical division
The Department of Health-Pharmaceutical Division (DOH-PD) conducted a face-to-face Program Implementation Review (PIR) and updates on the different programs of the Pharmaceutical Division in Coron Palawan last April 26-28, 2022 after two years of restrictions from the COVID-19 pandemic. The review is conducted annually and aims for viable and sustainable support for the continual strengthening of the capacity development and capacity building of the DOH Center for Health Development (CHD) operations in coordination with the National Drug Policy Compliance Officers (NDPCOs) and Public Health Pharmacist (PHPs).
The Program Implementation Review and updates on the different programs of the Pharmaceutical Division was opened by Atty. Charade B. Mercado-Grande, Undersecretary of the Health Regulation Team. She expressed appreciation for the efforts, hard work, courage, and selflessness of PHPs during the COVID-19 pandemic for continuing to monitor the availability of medicines in health facilities and also their contribution to the COVID-19 vaccination program.
Ms. Sarah M. Manga, Pharmacist IV and Unit Head of Program Implementation and Monitoring Unit (PIMU) of the Pharmaceutical Division presented the summarized accomplishments, issues, and concerns of the CHDs in the different PD programs. The presentation brought up salient reports and issues on procurement, supply chain management, logistics, and human resource concerns from areas of the different regions.
The three-day PIR also involved relevant offices and partners such as Supply Chain Management Service (SCMS), Disease Prevention and Control Bureau (DPCB), Procurement Service (PS), and Medicines, Technologies and Pharmaceutical Services (MTaPS) to undertake the systematization, strategic plans, and commitment of the healthcare teams and their role in the medicines management and the overall Pharmaceutical Supply Chain Management (PSCM) and Rational Use of Medicine (RUM).
Dr. Anna Melissa S. Guerrero, Director IV of the Pharmaceutical Division, emphasized that while it is important to bring to light implementation challenges on the ground, the DOH together with the regional health offices must continue to forge innovative solutions to address the challenges.
The COVID-19 pandemic imposed significant demands on our healthcare system which nonetheless revealed the selflessness, devotion, and resilience of our healthcare workers to continue to work together in providing the finest healthcare services to our Filipino people. Together, we fight, defeat, and heal as one in the face of adversity.
Telephone Number: 02-8757734 Loc. 253
Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City
Email Address: firstname.lastname@example.org